Gilead (GILD) Q3 2026 Earnings Call Transcript
The transcript of Gilead's third-quarter 2026 earnings call reports base business sales growth of 16%, described as the strongest growth in over a decade.
fool.com ·
Supported Assets
Open Mo
Gilead Sciences
24/7
-
-over selected period
-since US close
- Last close
- $167.47
- Premium / discount
- -
Updated Reference Yahoo Finance ·
Price differences before fees and execution costs. Compare prices
News
Gilead CEO Takes Aim at Medicare Pricing: 'Pill Penalty' Threatens Drug Innovation
Benzinga reported that Gilead raised its 2026 sales forecast after third-quarter earnings beat Wall Street estimates, helped by strong demand for its HIV drugs.
benzinga.com ·
Gilead (GILD) Q3 2026 Earnings Call Transcript
On its third-quarter 2026 earnings call, Gilead reported that base business sales surged 16%, which the transcript describes as its strongest growth in over a decade.
fool.com ·
Token
- Token
- GILDc
- Shares per token
- 1.00000000 GILD